Sundaram Brake Linings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 7:16 pm

Competitors of Sundaram Brake Linings Ltd

All Competitor Stocks of Sundaram Brake Linings Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:00 am

Below is a detailed analysis of the quarterly data for Sundaram Brake Linings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 92.01 Cr.. The value appears to be declining and may need further review. It has decreased from 96.96 Cr. (Mar 2025) to 92.01 Cr., marking a decrease of 4.95 Cr..
• For Expenses, as of Jun 2025, the value is 90.42 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 93.58 Cr. (Mar 2025) to 90.42 Cr., marking a decrease of 3.16 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.59 Cr.. The value appears to be declining and may need further review. It has decreased from 3.38 Cr. (Mar 2025) to 1.59 Cr., marking a decrease of 1.79 Cr..
• For OPM %, as of Jun 2025, the value is 1.73%. The value appears to be declining and may need further review. It has decreased from 3.49% (Mar 2025) to 1.73%, marking a decrease of 1.76%.
• For Other Income, as of Jun 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.89 Cr. (Mar 2025) to 0.53 Cr., marking a decrease of 0.36 Cr..
• For Interest, as of Jun 2025, the value is 1.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.18 Cr. (Mar 2025) to 1.02 Cr., marking a decrease of 0.16 Cr..
• For Depreciation, as of Jun 2025, the value is 1.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.35 Cr. (Mar 2025) to 1.59 Cr., marking an increase of 0.24 Cr..
• For Profit before tax, as of Jun 2025, the value is -0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 1.74 Cr. (Mar 2025) to -0.49 Cr., marking a decrease of 2.23 Cr..
• For Tax %, as of Jun 2025, the value is 8.16%. The value appears to be improving (decreasing) as expected. It has decreased from 24.14% (Mar 2025) to 8.16%, marking a decrease of 15.98%.
• For Net Profit, as of Jun 2025, the value is -0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 1.32 Cr. (Mar 2025) to -0.53 Cr., marking a decrease of 1.85 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.35. The value appears to be declining and may need further review. It has decreased from 3.35 (Mar 2025) to -1.35, marking a decrease of 4.70.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:21 am

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: October 10, 2025, 3:02 pm

Below is a detailed analysis of the balance sheet data for Sundaram Brake Linings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Mar 2024) to 95.00 Cr., marking an increase of 4.00 Cr..
• For Borrowings, as of Mar 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 44.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 70.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 67.00 Cr. (Mar 2024) to 70.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 225.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 206.00 Cr. (Mar 2024) to 225.00 Cr., marking an increase of 19.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 154.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2024) to 154.00 Cr., marking an increase of 17.00 Cr..
• For Total Assets, as of Mar 2025, the value is 225.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Mar 2024) to 225.00 Cr., marking an increase of 19.00 Cr..

Notably, the Reserves (95.00 Cr.) exceed the Borrowings (56.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Sundaram Brake Linings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 13.15. This value is within the healthy range. It has decreased from 25.65 (Mar 24) to 13.15, marking a decrease of 12.50.
• For Diluted EPS (Rs.), as of Mar 25, the value is 13.15. This value is within the healthy range. It has decreased from 25.65 (Mar 24) to 13.15, marking a decrease of 12.50.
• For Cash EPS (Rs.), as of Mar 25, the value is 28.31. This value is within the healthy range. It has decreased from 41.88 (Mar 24) to 28.31, marking a decrease of 13.57.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 252.51. It has increased from 241.60 (Mar 24) to 252.51, marking an increase of 10.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 252.51. It has increased from 241.60 (Mar 24) to 252.51, marking an increase of 10.91.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. It has decreased from 2.00 (Mar 24) to 1.50, marking a decrease of 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 895.17. It has decreased from 895.54 (Mar 24) to 895.17, marking a decrease of 0.37.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 41.01. This value is within the healthy range. It has decreased from 54.12 (Mar 24) to 41.01, marking a decrease of 13.11.
• For PBIT / Share (Rs.), as of Mar 25, the value is 25.85. This value is within the healthy range. It has decreased from 37.89 (Mar 24) to 25.85, marking a decrease of 12.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 15.61. This value is within the healthy range. It has decreased from 29.34 (Mar 24) to 15.61, marking a decrease of 13.73.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 13.15. This value is within the healthy range. It has decreased from 25.65 (Mar 24) to 13.15, marking a decrease of 12.50.
• For PBDIT Margin (%), as of Mar 25, the value is 4.58. This value is below the healthy minimum of 10. It has decreased from 6.04 (Mar 24) to 4.58, marking a decrease of 1.46.
• For PBIT Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 10. It has decreased from 4.23 (Mar 24) to 2.88, marking a decrease of 1.35.
• For PBT Margin (%), as of Mar 25, the value is 1.74. This value is below the healthy minimum of 10. It has decreased from 3.27 (Mar 24) to 1.74, marking a decrease of 1.53.
• For Net Profit Margin (%), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 5. It has decreased from 2.86 (Mar 24) to 1.46, marking a decrease of 1.40.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.20. This value is below the healthy minimum of 15. It has decreased from 10.61 (Mar 24) to 5.20, marking a decrease of 5.41.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.01. This value is below the healthy minimum of 10. It has decreased from 13.60 (Mar 24) to 9.01, marking a decrease of 4.59.
• For Return On Assets (%), as of Mar 25, the value is 2.30. This value is below the healthy minimum of 5. It has decreased from 4.89 (Mar 24) to 2.30, marking a decrease of 2.59.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.04, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.56. This value is within the healthy range. It has increased from 0.46 (Mar 24) to 0.56, marking an increase of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.63. It has decreased from 1.71 (Mar 24) to 1.63, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.35 (Mar 24) to 1.31, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 24) to 0.86, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.76. This value is below the healthy minimum of 4. It has increased from 3.69 (Mar 24) to 3.76, marking an increase of 0.07.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.21. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 15.21, marking an increase of 15.21.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.06. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 7.06, marking an increase of 7.06.
• For Earning Retention Ratio (%), as of Mar 25, the value is 84.79. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.79, marking an increase of 84.79.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.94. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 92.94, marking an increase of 92.94.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.01. This value is within the healthy range. It has decreased from 6.33 (Mar 24) to 4.01, marking a decrease of 2.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 3. It has decreased from 4.00 (Mar 24) to 2.28, marking a decrease of 1.72.
• For Enterprise Value (Cr.), as of Mar 25, the value is 344.33. It has increased from 310.52 (Mar 24) to 344.33, marking an increase of 33.81.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.88 (Mar 24) to 0.97, marking an increase of 0.09.
• For EV / EBITDA (X), as of Mar 25, the value is 21.34. This value exceeds the healthy maximum of 15. It has increased from 14.58 (Mar 24) to 21.34, marking an increase of 6.76.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.82, marking an increase of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 84.78. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.78, marking an increase of 84.78.
• For Price / BV (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.80 (Mar 24) to 2.91, marking an increase of 0.11.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.82, marking an increase of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness